We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$6.79B
AUM Growth
+$59.3M
Cap. Flow
+$258M
Cap. Flow %
3.8%
Top 10 Hldgs %
31.15%
Holding
445
New
88
Increased
128
Reduced
148
Closed
48

Sector Composition

Rank Sector Weight
1 Energy 58.32%
2 Industrials 8.26%
3 Financials 6.76%
4 Consumer Discretionary 5.23%
5 Technology 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
301
Pultegroup
PHM
$24.5B
$1.23M 0.02%
+52,049
New +$1.12M
GPN icon
302
Global Payments
GPN
$22.1B
$1.22M 0.02%
15,165
+7,121
+89% +$558K
APTV icon
303
Aptiv
APTV
$12B
$1.22M 0.02%
+15,166
New +$1.14M
MRI.A
304
DELISTED
MCRAE INDUSTRIES DEL CL A
MRI.A
$1.21M 0.02%
41,767
-1,118
-3% -$32.4K
BC icon
305
Brunswick
BC
$5.19B
$1.19M 0.02%
19,454
+4,458
+30% +$263K
POST icon
306
Post Holdings
POST
$4.12B
$1.19M 0.02%
20,709
+4,994
+32% +$275K
BX icon
307
Blackstone
BX
$104B
$1.18M 0.02%
39,852
GVA icon
308
Granite Construction
GVA
$5.45B
$1.18M 0.02%
23,545
-37,689
-62% -$2.01M
OAK
309
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$1.16M 0.02%
25,646
MIDD icon
310
Middleby
MIDD
$6.05B
$1.16M 0.02%
8,469
-1,916
-18% -$261K
MSGS icon
311
Madison Square Garden
MSGS
$9.54B
$1.16M 0.02%
8,108
+3,184
+65% +$414K
LAZ icon
312
Lazard
LAZ
$4.37B
$1.13M 0.02%
24,643
+13,544
+122% +$584K
VTR icon
313
Ventas
VTR
$48.9B
$1.07M 0.02%
16,531
-314
-2% -$19.6K
LOXO
314
DELISTED
Loxo Oncology, Inc
LOXO
$1.03M 0.02%
+24,419
New +$1.01M
TT icon
315
Trane Technologies
TT
$106B
$1.01M 0.01%
12,407
-1,510
-11% -$120K
KCG
316
DELISTED
KCG Holdings, Inc.
KCG
$1M 0.01%
56,135
-38,745
-41% -$576K
TCOM icon
317
Trip.com Group
TCOM
$27.5B
$995K 0.01%
20,253
+7,690
+61% +$352K
WGO icon
318
Winnebago Industries
WGO
$870M
$991K 0.01%
33,887
-31,687
-48% -$1.01M
NBIX icon
319
Neurocrine Biosciences
NBIX
$17.7B
$943K 0.01%
21,768
-22,112
-50% -$947K
SGRY icon
320
Surgery Partners
SGRY
$2.06B
$940K 0.01%
+48,191
New +$937K
XOP icon
321
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
$938K 0.01%
6,265
LXRX icon
322
Lexicon Pharmaceuticals
LXRX
$1.02B
$909K 0.01%
63,423
-8,269
-12% -$123K
RJF icon
323
Raymond James Financial
RJF
$32.5B
$898K 0.01%
+17,666
New +$899K
WYNN icon
324
Wynn Resorts
WYNN
$10.1B
$895K 0.01%
+7,808
New +$779K
AERI
325
DELISTED
Aerie Pharmaceuticals
AERI
$881K 0.01%
+19,427
New +$866K

Similar funds

Advisory Research's Q1 2017 Portfolio in Review

As of Q1 2017, Advisory Research held 445 positions worth $6.79B, up 0.88% from $6.73B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Advisory Research deployed $258M of net new capital in Q1 2017, opening 88 new positions and adding to 128 existing holdings. Its largest new stake was Enbridge: 1,369,737 shares worth $57.3M.

By sector, the portfolio is most concentrated in Energy at 58% of assets, down from 59% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Allied World Assurance Co Hld Lt, an estimated $56.7M trimmed.

  • Advisory Research's largest Q1 2017 buy was Enbridge: 1,369,737 shares worth $57.3M.
  • Advisory Research added most to EnLink Midstream Partners, LP in Q1 2017, an estimated $20M increase.
  • Advisory Research's biggest Q1 2017 reduction was Allied World Assurance Co Hld Lt, cutting an estimated $56.7M.
  • Advisory Research fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $51.4M.
  • Advisory Research's ten largest holdings make up 31% of its $6.79B portfolio in Q1 2017.
  • Advisory Research opened 88 new positions and closed 48 in Q1 2017.
  • Advisory Research's portfolio value rose 0.88% quarter-over-quarter to $6.79B.

Based on Advisory Research's 13F filing for Q1 2017, filed 15 May 2017.